The p53 gene is often mutated during cancer development. Frequency and functional consequences of these mutations vary in different tumor types. We analysed conformation and temperature dependency of 23 partially inactivating temperature-dependent (td) p53 mutants derived from various human tumors in yeast. We found considerable differences in transactivation capabilities and discriminative character of various p53 mutants. No correlations in transactivation rates and conformations of the td p53 proteins were detected. Amifostine-induced p53 reactivation occurred only in 13 of 23 td mutants, and this effect was temperature dependent and responsive element specific. The most of the p53 mutations (10/13) reactivated by amifostine were located in the part of the p53 gene coding for hydrophobic b-sandwich structure of the DNA-binding domain.
Introduction
p53 is a sequence-specific transcription factor controlling expression of multiple target genes and participating in regulation of many cellular processes, such as cell cycle, apoptosis, senescence and genome stability. It mediates reaction of cell to various stress signals (Levine et al., 2006) . The p53 protein controls expression of at least 50 target genes through direct binding to their responsive elements (REs). The nucleotide sequences of REs are related but not identical (Di Como and Prives, 1998; Inga et al., 2002) . They can be divided into 'highaffinity' and 'low-affinity' groups according to the strength of the p53 binding. For example, the p21 promoter appears to contain high-affinity binding site, whereas the p53-binding site of the bax promoter possesses lower affinity. Thus, even the fully functional p53 wt protein can bind distinct subclasses of the target genes differently (Friedlander et al., 1996) .
Inactivation of p53 is a common event during cancer development. The majority of p53 mutations are missense. They are scattered along the entire p53 gene with a strong predominance in the DNA-binding domain (Petitjean et al., 2007) . Thus far, more than 1200 distinct tumor-derived point mutations have been reported. The p53 mutants differ in capacity to transactivate specific targets. For example, they are (1) inactive p53 mutants that cannot transactivate any target gene, (2) discriminating mutants that can transactivate some target genes but not the others, typified by mutants retaining ability to transactivate p21 but unable to transactivate the target genes involved in apoptosis (Ludwig et al., 1996) and (3) conditional mutants that are active only under specific conditions, for example, in limited temperature or pH ranges (DiGiammarino et al., 2002) .
The high degree of heterogeneity of p53 mutants provoked development of various procedures capturing p53 mutations with increased sensitivity and specificity. Functional analysis of separated alleles in yeast (FASAY) (Ishioka et al., 1993) detects p53 mutations interfering with transactivation ability of the p53 protein. If transcriptionally competent p53 is present in analysed material, FASAY provides white yeast colonies. The absence of p53wt results in formation of red colonies. In addition, FASAY can recognize the p53 mutations affecting transactivation function of p53 only partially, including the temperaturedependent mutations (Flaman et al., 1995) .
Temperature-dependent (td) p53 mutants represent an interesting category of p53 mutants featuring only limited and reversible perturbations of the thermodynamic equilibrium of the DNA-binding domain. They can be functionally rescued just by temperature shift toward the permission value. Therefore, they might be also more vulnerable to functional rescue by small molecules. Using FASAY, we set up a panel of 23 partially inactivating p53 mutants derived from various human tumors and analysed their discriminative character, temperature dependency, conformations and response to amifostine in yeast.
Results

Collection of temperature-dependent p53 mutations
Based on phenotypes of the yeast colonies, we identified a panel of 23 partially inactivating, td p53 mutations (Smardova et al., 2001 (Smardova et al., , 2004 Pavlova et al., 2003; Nenutil et al., 2005) . Nineteen of them were found temperaturesensitive (ts) and four cold-sensitive (cs) ( Table 1) . Three of these mutations (P98A, I254N, V274G) are not included in the IARC functional database (R11) of p53 mutations (http://www.iarc.fr/p53; Olivier et al., 2002) . For the first time, we document temperature sensitivity of p53 resulting from amino acid substitutions in positions 98, 110, 195 and 344 (P98A, R110L, I195T, L344R) . Six p53 mutations (C135G, A159V, V216M, M237K, I254N, V272G) cause amino acid substitutions that have not been published yet, although temperature-sensitivity resulting from mutations of the same codons was reported earlier (Shiraishi et al., 2004; Dearth et al., 2007) . Three additional ts p53 mutations (Y205C, G266E, R337C) were previously described as temperature resistant Smardova et al., 2001; Resnick and Inga, 2003; Dearth et al., 2007) .
Transactivation by temperature-dependent p53 mutants in yeast Temperature-dependent (td) p53 mutants often discriminate (Di Como and Prives, 1998; Flaman et al., 1998; Campomenosi et al., 2001) . For analysis of the p53 status, we used yeast cells yIG397 containing the ribosomal gene cluster (RGC)-derived p53-RE placed upstream of the ADE2 reporter gene (Flaman et al., 1995) . To explore the discriminative character of the td p53 mutants, we expressed the p53 variants also in yeast strains YPH-p21 and YPH-bax. These strains possess the p53-RE derived from the regulatory region of the p21 and bax genes, respectively, placed upstream of the ADE2 (Flaman et al., 1998) .
To assess temperature dependency and discriminative character, the p53 variants were used for transformation of YPH-p21 and YPH-bax cells. The p53 hotspot mutants R175H and R248W were used as negative controls; the p53wt was used as positive control. Transformants were grown on selection media and incubated at 25, 30 and 35 1C for 4 days. Relative transactivation by p53 was semi-quantitatively assessed according to the color of resulting yeast colonies ( Figure 1a ). First, we empirically established a sevenstep color scale of yeast colonies differing in the tone of red color between the end points represented by white colonies of p53wt transformants, and the darkest red colonies of hotspot p53 mutants (Figure 1b) . The scale than served as a tool for assessment of transactivation ability of the p53 variants. The td p53 mutations differed in the level of temperature sensitivity (Figure 2 ) and the most of ts and cs p53 mutants were discriminating indeed. The differences in transactivating capabilities of the p53 mutants were considerable. Activity of some mutants almost reached the same level as the p53wt at 35 1C (P222L), while some others were inactivated almost as much as the hotspot mutants leaving weak According to Cho et al. (1994) .
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D Grochova et al activity at 25 1C (Y126C, Y205C, V216M, G266E, E286K and others). The p53 mutants also differed in discriminating character. Some of them, such as A159V and V216M, possessed a similar activity in all three promoters tested, while the others, such as C135G, I195T and I234N, significantly differed in transactivation from different promoters. The p53 mutants P98A, P222L, L344R and partially R377C were cs.
Phenotype of the yeast colonies does not depend on the p53 protein level It has been shown previously that transactivation by p53 can be affected by its intracellular concentration (Inga et al., 2002) . Therefore, we examined the expression of all p53 variants in all three yeast strains by immunoblotting using p53-specific antibody DO-1. However, the level of p53 was comparable in all yeast strains and temperatures (Figure 3 ).
Conformation of temperature-dependent p53 mutant proteins in yeast
Conformation of the p53 protein is crucial for its function. Many missense mutations change conformation of p53, thus they can be recognized by monoclonal antibody PAb240. This antibody is specific for denatured p53. Its specific linear epitope (located at amino acid residues 212-217) is rather cryptic in the native p53wt structure, but is exposed at surface of many p53 mutants (Gannon et al., 1990; Stephen and Lane, 1992) . In contrast, PAb1620 interacts preferentially with the native p53wt protein while its affinity to denatured or mutant p53 is lower (Milner et al., 1987; Gannon et al., 1990) . Conformation of some ts p53 mutants, for example, 143A or V272M, is flexible and can switch from wt conformation at the permissive temperature to mutant conformation at the restrictive temperature (Zhang et al., 1994) .
To assess conformation and temperature dependency of analysed p53 variants, we cultured yeast cells Analysis of p53 td mutants in yeast D Grochova et al expressing these p53 variants at 25, 30 and 35 1C. The p53 protein was immunoprecipitated from lysates of harvested cells using PAb240 and PAb1620 antibodies. As a positive control, we used the DO-1 antibody recognizing the p53 N-terminal domain (Figure 4a) . Each p53 variant was tested in parallels that provided similar results. The ratio of PAb1620-and PAb240-specific immunocomplexes from one of these experiments was determined by densitometry ( Figure 4b) . Results of these analyses are summarized in Figure 5 . All the p53 protein variants were successfully precipitated using PAb1620, PAb240 and DO-1 antibodies at 25, 30 and 35 1C. However, the ratio of PAb1620-and PAb240-specific immunocomplexes as well as its temperature dependency considerably differed among the p53 variants. As expected, the highest proportion of the PAb1620-specific fraction was detected in p53wt (the average for all temperatures reached 67%). Similar results were found for the p53 mutants E286V, I195T, S215G, V274G, M237K, V272G and P222L (range from 63 to 52%). Surprisingly, high score of the PAb1620-specific fraction was also reached in sample of hotspot mutant R175H (61%). In contrast, the lowest proportion of the PAb1620-specific fraction was detected in mutants E286K, A138V, R110L and Y220C (up to 40%). The hotspot mutant R248W scored 42% of the PAb1620-specific fraction. The level of temperature dependency of PAb1620/PAb240 ratio was different in various p53 mutants. While in some mutants the ratio correlated with the temperature (P98A, Y126C, S215G, M237K, I254N, E285K, E286K, E286V), in the other cases the ratio was either temperature independent (I195T, V274G) or irregular (for example, R110L, A138V, Y220C, Y205C).
Transactivation by temperature-dependent p53 mutants does not correlate with protein conformation in yeast We compared the average transactivation from all three promoters by each p53 variant with the average ratio of the PAb1620-specific immunocomplexes ( Figure 6 ). As expected, the p53wt scored the highest transactivation rate as well as the highest proportion of the PAb1620-specific conformation. However, no correlation of transactivation rate and protein conformation was observed in td p53 proteins. The hotspot mutants R175H and R248W lost transactivation capacity but they scored reasonably high proportion of the PAb1620-specific conformation (61 and 42%, respectively).
Reactivation of td p53 mutants by amifostine in yeast It has been shown earlier that cytotoxic drug amifostine (WR2721) induces DNA-binding activity of p53wt and restores activity of some ts p53 mutants (North et al., 2000; Maurici et al., 2001; Pavlova et al., 2003) . In order to test the ability of amifostine to restore the transactivating activities of td p53 mutants, we determined the optimal concentration of amifostine for the yeast expression system. Using amifostine concentration range 0, 4, 6, 8, 10 and 12 mM, the mutant Y234C (33 1C) and the color scale of the yeast colonies, we showed that restoration of the p53 transactivation correlates with increasing dose of amifostine. The strongest effect was induced by 8 mM and 10 mM amifostine. The 12 mM concentration was partially toxic for yeast colonies. Therefore, we chose 8 mM concentration to test the effects of amifostine on transactivation of the td p53 mutants using different cultivation temperatures and the p53-REs. Similar results were described by Maurici et al. (2001) . We examined the response of the td p53 mutants to amifostine in different temperatures and the p53-REs. Yeast cells expressing various p53 variants were plated in selection medium containing or lacking amifostine and incubated at 25, 28, 30, 33 and 35 1C for 3-4 days. Then, the relative transactivation by p53 was assessed according to the color of resulting colonies (Figure 1b) . Reactivation by amifostine occurred only in 13 from 23 td mutants (P98A, C135G, A159V, I195T, Y205C, S215G, V216M, Y234C, M237K, G266E, V272C, V274G, E285K), and this effect was temperature-and RE-dependent. The p53 reactivation by amifostine occurred preferentially in 33 1C and in RGC-derived RE (Figure 7a ). The effect of amifostine was weak but reproducible. The most efficient reactivation by amifostine occurred in Y234C (Figure 8a) . To evaluate the effect of amifostine on conformation of this p53 protein variant, the yeast cells yIG397 expressing Y234C were cultured at 33 and 35 1C in duplicate in selection medium containing and lacking the amifostine. The p53 protein was immunoprecipitated from lysates of harvested cells using PAb240 and PAb1620, the immunocomplexes were resolved by SDS-PAGE and immunoblotted using p53-specific polyclonal antibody CM1 (Figure 8b ). The ratio of PAb1620-and PAb240-specific immunocomplexes was determined by densitometry (Figure 8c ). The result suggests that the recovery of transactivation ability of the p53 mutant Y234C might result from restored native, PAb1620-specific conformation of the p53 protein indeed.
Discussion
There are many ways of the p53 protein inactivation (reviewed by Smardova et al., 2005) . The most common mechanism is based on mutations abrogating the p53 transactivating function. Therefore, methods for analysis of the p53 status in clinical material are commonly targeting its transactivation capability. The FASAY is one of them.
Collection of td p53 mutations has been generated by analysis of multiple human tumors using FASAY. First, for routine analysis of the p53 status in clinical material, we used the RGC-derived RE. Thus, we cannot exclude that we miss the mutants which are temperature independent on RGC-derived RE, but are temperature dependent on the others. Second, it is difficult to define temperature dependency exactly. Even p53wt is ts (Hansen et al., 1996; Xirodimas and Lane, 1999 ; Figure 3 ). Thus, especially the p53 mutants with similar activity as p53wt or the hotspot p53 mutant can be easily missed. Nevertheless, efficiency of detection of the td p53 mutants in this study is similar as described by others. Frequency of temperature dependency in our collection of p53 mutants is 12.8% (24/188), while it has been shown that ts mutants represent 8.5% (8/94) of the p53 mutants detected in human tumor cell lines (Jia et al., 1997) . IARC database features 10.4% of ts mutants (1254/12032). From 2314 p53 mutants prepared by site-directed mutagenesis, the temperature sensitivity was attributed to 142 (6.1%) (Kato et al., 2003) . Many There is a high variability of transactivation rates of td p53 mutants. The temperature dependency might not be the crucial property of this type of mutations. The temperature dependency is often connected with discriminative character of p53 variants. Indeed, 17 of 23 td p53 mutants possessed discriminative character. They exhibited higher activity in the p21-derived RE and lower activity in the bax-derived RE. The Y126C, A159V, P222L and R337C mutants were not discriminative, and the discriminative character of P98A was temperature dependent. This mutant was more active in p21-derived RE in lower temperature (25 1C) and in baxderived RE in higher temperature (35 1C). Interestingly, the Y234C mutant behaved in exactly opposite way than the 'classic' discriminators. It was more active in the bax-derived RE than in the p21-derived RE. Frequency of discriminative mutants in td p53 mutants exceeded 80% (19/23), while frequency of discriminative mutants in unsorted p53 mutants reached 20% .
The PAb1620 antibody preferentially recognizes p53wt conformation, while the PAb240 preferentially recognizes mutant p53 conformation in human cells (Gannon et al., 1990) . In our system, the conformationspecific antibodies were less specific. Both p53wt and the hotspot p53 mutants were efficiently precipitated by both PAb1620 and PAb240. However, it has been accepted that rather than being in an exclusive Analysis of p53 td mutants in yeast D Grochova et al conformational state, some kind of equilibrium exists between the two conformations of p53 (Zhang et al., 1994; Hansen et al., 1996; Xirodimas and Lane, 1999 ). The allosteric model was proposed for structure of the p53 tetramer. It predicts that the equilibrium shifts by high concentrations of latent p53 protein, the p53 mutations and post-translational modifications (Lane and Hupp, 2003) . It explains why it may be difficult for the p53 protein to get the 'right' conformation, especially in heterologous system: (1) rather strong constitutive level of human p53 expression is reached in our yeast system, (2) in contrast to human cells, p53 does not undergo physiological post-translational modifications in yeasts, (3) in its physiological environment, many other factors affect behavior and function of the p53 protein, many of them might be absent from the non-human cell system (McLure and Lee, 1999; Gaitonde et al., 2000) . Indeed, the discrepancy between the type of the p53 conformation and the level of its transactivation ability was documented several times in yeast cells (Scharer and Iggo, 1992; Ory et al., 1994) and our data strongly support this finding. In addition, even the phenomenon of discriminativity itself suggests that there is no ultimate 'active' conformation of the p53. The p53 must be capable of getting the conformations that are active in some response elements and inactive in others in the presence and absence of additional factors.
Recently, great effort has been spent to find the way how to rescue the abrogated p53 function in tumor cells (Selivanova and Wiman, 2007) . It has been shown previously that amifostine can activate the p53wt (North et al., 2000; Pataer et al., 2006) . Although in some systems, amifostine does not reactivate mutated p53 (Acosta et al., 2003) , it can restore the PAb1620-specific conformation and reactivate transactivation function of ts p53 mutant V272M in human cells (North et al., 2002) . This effect occurs also in yeast cells (Maurici et al., 2001) . Based on these results as well as on our own study (Pavlova et al., 2003) , we tested the reactivation of the td p53 mutants by amifostine in yeasts. The effect of amifostine was detected in 13 of 23 td p53 mutants. The results presented in this study suggest that location of the p53 mutation affects the reactivation potency of amifostine. A total of 10 out of these 13 mutations were located in the sequence coding for the hydrophobic b-sandwich structure of the p53 DNA-binding domain. This domain contains two large loops (L2 and L3) and the helix-sheet-helix motive essential for direct binding to DNA. This structure acts as a scaffold for two large loops (L2 and L3) and the loop-sheet-helix motive which are responsible for the direct DNA binding. We propose that these structures are stabilized by amifostine which is partially restoring function of the DNA-binding domain.
The structure-function relationships of td mutants were studied by mapping mutations on the crystal structure of p53 (Cho et al., 1994) . Detailed description of these relationships for each individual mutant in comparison with published data can be found in Supplementary Material. Most of the td mutations (87%) are located in the sequence coding for DNA-binding domain; 56% of them in the sequence coding for the b-strands. Four td mutants affected the loop structure and three the H2 helix. Three td mutants were located outside the DNA-binding domain-coding region; the P98A mutant in the proline-rich domain and the R337C and L344R mutants in the C-terminal tetramerization domain-coding regions. Our results are consistent with data obtained by Shiraishi et al. (2004) who isolated 142 ts p53 mutations from a comprehensive missense mutation library. Most of them (131/142; 92%) were mapped in the core DNA-binding domain, and 50% (71/142) of these mutations in b-strands. Our results support hypothesis by Shiraishi et al. (2004) that b-strands of p53 possess more ts substructure than a-helices and loops of the DNA-binding domain. The conditional flexibility of these b-strands is also supported by another observation, that most of the td mutants (10/13; 77%) reactivated by amifostine were located in the b-strands and their side chains were pointing toward the core of b-sandwich of DNAbinding domain. Our data are in contrast with the observations of Maurici et al. (2001) who analysed reactivation by amifostine of 15 p53 mutants. All their responders fall within the flexible loops leaving the b-sheet scaffold intact. In our set of td mutants which were not reactivated by amifostine, two mutants (R337C and L344R), were located in the tetramerization domain supporting our hypothesis that amifostine primarily affects the hydrophobic core of b-sandwich structure of the DNA-binding domain. Other three mutants that are not reactivated by amifostine (E286K, E286V and Y126C) make contacts with the residues E286 and Y126 which directly interact via hydrogen bond with the hotspot residue R282. Amifostine is not able to restore hydrogen bonding in these mutants.
Our data support the view that establishing of the functional status of mutated p53 is important for efforts to reactivate p53 in tumor cells. Our results suggest that ts and thus conformation-flexible p53 mutants are more amendable to reactivation. We also show that even the yeast system, although it does not reflect all properties to the p53 variants, is convenient for this type of studies.
Materials and methods
FASAY FASAY was performed as described earlier (Flaman et al., 1995; Smardova et al., 2001) . Total RNA was purified using RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA). cDNA was synthesized by SuperScript II (Invitrogen Corp., Carlsbad, CA, USA) using oligo(dT) 12 as a primer. PCR was performed using primers P3 (5 0 -CCTTGCCGTCCCAAGCAATGGAT GAT-3 0 ), P4 (5 0 -ACCCTTTTTGGACTTCAGGTGGCTG GAGT-3 0 ) and Pfu DNA Polymerase (Stratagene, La Jolla, CA, USA). Yeast cells were co-transformed with the PCR product, linearized pSS16, and the salmon sperm DNA carrier (Invitrogen) by the lithium acetate procedure (Ishioka et al., 1993) . Transformed yeast cells were plated on minimal medium lacking leucine and with a low amount of adenine (5 mg ml À1 ), followed by incubation at 35 1C for 2-3 days, and then for 2-3 days at room temperature.
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Recovery of the p53-expressing plasmid from yeast and sequencing of the p53 cDNA Yeasts harboring the p53 plasmid were lysed with the enzymes of Trichoderma harzianum (Sigma-Aldrich, Prague, Czech Republic) and the p53 expression plasmid was extracted. The central part of the p53 gene was amplified by PCR using P3 and P4 primers and Taq polymerase (Invitrogen). The PCR product was purified from a gel by MinElute PCR Purification Kit (Qiagen) and sequenced by BigDyeTermintor v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) using ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
Immunoblotting and immunoprecipitation
Cells were lysed with buffer containing 150 mM NaCl, 50 mM NaF, 50 mM Tris (pH 8.0), 5 mM EDTA, 1% NP40 and 1 mM phenylmethylsulfonylfluoride protease inhibitor in ice for 30 min, and the cell extract was centrifuged at 17 000 g for 30 min to remove cell debris. For preparation of cell extracts, yeast colonies were seeded in YPDA medium and harvested at OD 600 0.8-1.0. Cells were washed with sterile ice-cold water and lysed with a lysis buffer enriched by one volume of sterile glass beads and shortly vortexed every 5 min during next 1 h. Lysates were cleared by centrifugation at 17 000 g for 30 min.
Protein concentration was measured by the Bradford assay. Solubilized proteins were separated by 10% SDS-PAGE and transferred onto a nitrocellulose membrane. Blots were blocked in 0.1% Tween 20 and 5% low-fat milk in phosphate buffered saline for 1 h, probed with anti-p53 antibody DO-1 at 4 1C. Blots were developed with Dako peroxidase-conjugated rabbit anti-mouse immunoglobulin using the ECL chemiluminiscent detection kit (Amersham Bidsciences, Vienna, Austria).
Immunoprecipitation of the p53 protein was performed using monoclonal antibodies DO-1, PAb240 and PAb1620. For both pre-absorption of the lysates and isolation of the antibody-p53 complexes, protein G-agarose beads (SigmaAldrich) were used. The immunocomplexes were analysed by immunoblotting with anti-p53 polyclonal antibody CM-I (Vision Biosystems, Newcastle upon Tyne, UK) and Dako peroxidase-conjugated swine anti-rabbit immunoglobulin.
Densitometry
Protein levels were evaluated by densitometry of immunoblots. BIO-1D (VILBER LOURMAT) software was used to evaluate relative levels of immunoprecipitated proteins.
Molecular modelling
Structure-function relationships of temperature-dependent mutants were studied with the core p53 DNA-binding domain solved by crystallographic analysis PDB ID 1TSR (Cho et al., 1994) using the visualization software PyMOL v0.99 (DeLano Scientific LLC, USA).
